Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
Panagiotakopoulos L, Godfrey M, Moulia DL, Link-Gelles R, Taylor CA, Chatham-Stephens K, Brooks O, Daley MF, Fleming-Dutra KE, Wallace M. Panagiotakopoulos L, et al. Among authors: moulia dl. MMWR Morb Mortal Wkly Rep. 2024 Apr 25;73(16):377-381. doi: 10.15585/mmwr.mm7316a4. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38662708 Free PMC article.
Development of COVID-19 vaccine policy - United States, 2020-2023.
Oliver SE, Wallace M, Twentyman E, Moulia DL, Godfrey M, Link-Gelles R, Meyer S, Fleming-Dutra KE, Hall E, Wolicki J, MacNeil J, Bell BP, Lee GM, Daley MF, Cohn A, Wharton M. Oliver SE, et al. Among authors: moulia dl. Vaccine. 2023 Dec 28:S0264-410X(23)01466-4. doi: 10.1016/j.vaccine.2023.12.022. Online ahead of print. Vaccine. 2023. PMID: 38158297 Free article.
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
Regan JJ, Moulia DL, Link-Gelles R, Godfrey M, Mak J, Najdowski M, Rosenblum HG, Shah MM, Twentyman E, Meyer S, Peacock G, Thornburg N, Havers FP, Saydah S, Brooks O, Talbot HK, Lee GM, Bell BP, Mahon BE, Daley MF, Fleming-Dutra KE, Wallace M. Regan JJ, et al. Among authors: moulia dl. MMWR Morb Mortal Wkly Rep. 2023 Oct 20;72(42):1140-1146. doi: 10.15585/mmwr.mm7242e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37856366 Free PMC article.
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
Fleming-Dutra KE, Jones JM, Roper LE, Prill MM, Ortega-Sanchez IR, Moulia DL, Wallace M, Godfrey M, Broder KR, Tepper NK, Brooks O, Sánchez PJ, Kotton CN, Mahon BE, Long SS, McMorrow ML. Fleming-Dutra KE, et al. Among authors: moulia dl. MMWR Morb Mortal Wkly Rep. 2023 Oct 13;72(41):1115-1122. doi: 10.15585/mmwr.mm7241e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37824423 Free PMC article.
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.
Wallace M, Rosenblum HG, Moulia DL, Broder KR, Shimabukuro TT, Taylor CA, Havers FP, Meyer SA, Dooling K, Oliver SE, Hadler SC, Gargano JW. Wallace M, et al. Among authors: moulia dl. Vaccine. 2023 Oct 20;41(44):6456-6467. doi: 10.1016/j.vaccine.2023.07.037. Epub 2023 Jul 30. Vaccine. 2023. PMID: 37527956 Free PMC article. Review.
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
Dalton AF, Diallo AO, Chard AN, Moulia DL, Deputy NP, Fothergill A, Kracalik I, Wegner CW, Markus TM, Pathela P, Still WL, Hawkins S, Mangla AT, Ravi N, Licherdell E, Britton A, Lynfield R, Sutton M, Hansen AP, Betancourt GS, Rowlands JV, Chai SJ, Fisher R, Danza P, Farley M, Zipprich J, Prahl G, Wendel KA, Niccolai L, Castilho JL, Payne DC, Cohn AC, Feldstein LR; CDC Multijurisdictional Mpox Case-Control Study Group; CDC Multijurisdictional Mpox Case Control Study Group. Dalton AF, et al. Among authors: moulia dl. MMWR Morb Mortal Wkly Rep. 2023 May 19;72(20):553-558. doi: 10.15585/mmwr.mm7220a3. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37200229 Free PMC article.
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
Deputy NP, Deckert J, Chard AN, Sandberg N, Moulia DL, Barkley E, Dalton AF, Sweet C, Cohn AC, Little DR, Cohen AL, Sandmann D, Payne DC, Gerhart JL, Feldstein LR. Deputy NP, et al. Among authors: moulia dl. N Engl J Med. 2023 Jun 29;388(26):2434-2443. doi: 10.1056/NEJMoa2215201. Epub 2023 May 18. N Engl J Med. 2023. PMID: 37199451
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
Rosenblum HG, Wallace M, Godfrey M, Roper LE, Hall E, Fleming-Dutra KE, Link-Gelles R, Pilishvili T, Williams J, Moulia DL, Brooks O, Talbot HK, Lee GM, Bell BP, Daley MF, Meyer S, Oliver SE, Twentyman E. Rosenblum HG, et al. Among authors: moulia dl. MMWR Morb Mortal Wkly Rep. 2022 Nov 11;71(45):1436-1441. doi: 10.15585/mmwr.mm7145a2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36355612 Free PMC article.
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022.
Twentyman E, Wallace M, Roper LE, Anderson TC, Rubis AB, Fleming-Dutra KE, Hall E, Hsu J, Rosenblum HG, Godfrey M, Archer WR, Moulia DL, Daniel L, Brooks O, Talbot HK, Lee GM, Bell BP, Daley M, Meyer S, Oliver SE. Twentyman E, et al. Among authors: moulia dl. MMWR Morb Mortal Wkly Rep. 2022 Aug 5;71(31):988-992. doi: 10.15585/mmwr.mm7131a2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35925807 Free PMC article.
16 results